Results with accelerated partial breast irradiation in terms of estrogen receptor, progesterone receptor, and human growth factor receptor 2 status.

@article{Wilder2010ResultsWA,
  title={Results with accelerated partial breast irradiation in terms of estrogen receptor, progesterone receptor, and human growth factor receptor 2 status.},
  author={Richard B. Wilder and Lisa D. Curcio and Rajesh K. Khanijou and Martin E Eisner and Jane L. Kakkis and L. E. . Chittenden and Jeffrey K Agustin and Jessica Lizarde and Alejandro Fern{\'a}ndez Mesa and Jorge C Macedo and John Ravera and Kenneth M. Tokita},
  journal={International journal of radiation oncology, biology, physics},
  year={2010},
  volume={78 3},
  pages={
          799-803
        }
}
PURPOSE To report our results with accelerated partial breast irradiation (APBI) in terms of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2/neu) status. METHODS AND MATERIALS Between February 2003 and June 2009, 209 women with early-stage breast carcinomas were treated with APBI using multicatheter, MammoSite, or Contura brachytherapy to 34 Gy in 10 fractions twice daily over 5-7 days. Three patient groups were defined by receptor… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-7 OF 7 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 40 REFERENCES

Similar Papers

Loading similar papers…